trial

Nicotine Effects on Endophenotypes of Schizophrenia

NCTId NCT01315002
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 121 (actual)
Sponsored by University Hospital, Bonn
Primary completion 2012-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
121 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2008-07
Primary completion
2012-03
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Transdermal nicotine patch

Sponsors

University Hospital, BonnLead Sponsor
German Research FoundationCollaborator

Investigators

2
Michael Wagner, Prof. Dr.Principal Investigator
Wolfgang Maier, Prof. Dr.Principal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
121
Phase
NA
Primary Completion Date
2012-03
Status
COMPLETED
relationships
The graph out of here
drug
Transdermal nicotine patch
drug
lead_sponsor
University Hospital, Bonn
company
collaborator
German Research Foundation
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Michael Wagner, Prof. Dr.
person
Wolfgang Maier, Prof. Dr.
person